|
시장보고서
상품코드
1807446
세계의 에피제네틱스 시장 : 규모, 점유율 및 동향, 업계 분석(제품별, 기술별, 용도별, 최종 용도별, 지역별), 예측(2025-2034년)Epigenetics Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Reagents, Enzymes, Equipment & Accessories, Software, Service), By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 에피제네틱스 시장 규모는 2034년까지 725억 7,000만 달러에 달할 전망입니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
에피제네틱스는 기본 DNA 서열의 변화를 동반하지 않는 유전자 발현의 변화에 대한 연구를 말합니다. 이러한 변화는 DNA 메틸화, 히스톤 변형, 비코딩 RNA 상호작용과 같은 화학적 변형에 의해 영향을 받습니다. 에피제네틱스 메커니즘은 발달, 노화, 환경 요인에 대한 반응을 포함한 다양한 생물학적 과정의 제어에 중요한 역할을 합니다. 이러한 변형을 이해하는 것은 연구자가 다른 세포에서 유전자가 어떻게 켜지거나 꺼지는지를 찾는 데 도움이 되며, 이는 암, 신경 질환, 자가면역 질환 등의 질병을 연구하는 데 중요합니다.
에피제네틱스 시장은 유전자 발현의 변화를 연구하기 위한 도구, 기술, 서비스의 개발과 제공에 초점을 맞추었습니다. 여기에는 연구 및 임상 장소에서 사용되는 키트, 시약, 효소, 장비, 소프트웨어, 관련 서비스 등의 제품이 포함됩니다. 질병 진행에 있어서의 에피제네틱스의 역할에 대한 인식 증가와, 개별화 의약품에 대한 수요 증가가 시장 확대의 원동력이 되고 있습니다. 시퀀싱 기술과 바이오 정보학의 진보는 에피제네틱스 연구를 더욱 가속화하여보다 정확한 진단과 표적 치료를 가능하게합니다. 이처럼 다양한 분야에서 에피제네틱 메커니즘에 대한 주목이 높아지고 있는 것은 시장을 확대하고 지속적인 혁신을 촉진하고 있습니다.
에피제네틱스 시장 : 분석 개요
제품별로는 키트 및 시약 분야가 2024년에 최대 점유율을 차지했습니다. 에피제네틱스 실험을 실시하는 데 필수적이며 연구 및 임상 실험실에서 널리 사용되기 때문입니다. 그 범용성과 용이성으로부터, 가장 수요가 높은 제품 유형이 되고 있습니다.
기술별로는 DNA 메틸화 분야가 2024년에 가장 큰 점유율을 차지했습니다. 그 이유는 유전자 제어와 질병 연구, 특히 암에서 중요한 역할을 하기 때문입니다. DNA 메틸화는 진단 및 치료 연구에 널리 사용되는 확립 된 방법입니다.
용도별로는 후성유전적인 변화가 암의 개발과 치료와 밀접하게 관련되어 있기 때문에 종양분야가 2024년에 최대 점유율을 차지했습니다. 암에서 에피제네틱 바이오마커와 표적 요법에 대한 수요가이 부문의 이점을 견인하고 있습니다.
최종 용도별로는 대학과 연구기관이 에피제네틱 도구의 1차 사용자이기 때문에 학술연구 부문은 2024년 최대 점유율을 차지했습니다. 강력한 자금 조달과 진행 중인 연구가 이 부문을 시장 수요의 핵심으로 삼고 있습니다.
지역별로 북미는 첨단 의료 인프라, 고액의 연구 자금, 혁신적인 에피제네틱스 기술의 조기 도입으로 세계의 주요 지역이 되고 있습니다. 북미는 후성 유전학 연구와 응용의 세계적인 허브로 계속되고 있습니다. 아시아태평양은 생명공학에 대한 투자가 증가하고 있으며, 의료 근대화에 점점 더 주력하고 있는 점에서 주목을 받고 있습니다. 에피제네틱스 연구의 이점에 대한 의식 증가와 만성 질환의 유병률의 확대는 후성 유전 기술의 채택을 촉진하고 있습니다.
이 시장의 주요 기업으로는 Thermo Fisher Scientific, Merck KGaA, QIAGEN, New England Biolabs, Agilent Technologies, Bio-Rad Laboratories, EpiGentek, Zymo Research Corporation, Diagenode, Active Motif, PerkinElmer, Illumina, Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계 에피제네틱스 시장 인사이트
- 시장 현황
- 에피제네틱스 시장 역학
- 성장 촉진요인과 기회
- 암 연구와 맞춤형 의료에 대한 주목 상승
- 에피제네틱스 분석 기술 진보
- 억제요인과 과제
- 표준화된 프로토콜과 해석의 부족
- 성장 촉진요인과 기회
- PESTLE 분석
- 후성 유전 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 에피제네틱스 시장 : 제품별
- 주요 분석 결과
- 소개
- 키트 및 시약
- 효소
- 기기 및 액세서리
- 소프트웨어
- 서비스
제6장 세계의 에피제네틱스 시장 : 기술별
- 주요 분석 결과
- 소개
- DNA 메틸화
- 히스톤 메틸화
- 히스톤 아세틸화
- 라지 비코딩 RNA
- 마이크로 RNA 변형
- 크로마틴 구조
제7장 세계의 에피제네틱스 시장 : 용도별
- 주요 분석 결과
- 소개
- 종양
- 대사 장애
- 면역 질환
- 발생생물
- 심혈관 질환
- 기타
제8장 세계의 에피제네틱스 시장 : 최종 용도별
- 주요 분석 결과
- 소개
- 학술연구
- 임상 연구
- 병원 및 진료소
- 제약 및 바이오테크놀러지 기업
- 다른 사용자
제9장 세계의 에피제네틱스 시장 : 지역별
- 주요 분석 결과
- 소개
- 에피제네틱스 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별（2020-2034년）
- 유럽 : 기술별（2020-2034년）
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- Active Motif
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Diagenode SA
- EpiGentek Group Inc.
- Illumina, Inc.
- Merck KGaA
- New England Biolabs, Inc.
- PerkinElmer, Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
- Zymo Research Corporation
The global epigenetics market size is expected to reach USD 72.57 billion by 2034, according to a new study by Polaris Market Research. The report "Epigenetics Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Reagents, Enzymes, Equipment & Accessories, Software, Service), By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Epigenetics refers to the study of changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes are influenced by chemical modifications such as DNA methylation, histone modification, and non-coding RNA interactions. Epigenetic mechanisms play a crucial role in regulating various biological processes, including development, aging, and response to environmental factors. Understanding these modifications helps researchers explore how genes are turned on or off in different cells, which is important for studying diseases such as cancer, neurological disorders, and autoimmune conditions.
The epigenetics market focuses on developing and providing tools, technologies, and services to study gene expression changes. It includes products such as kits, reagents, enzymes, instruments, software, and related services used in research and clinical settings. Growing awareness of epigenetics' role in disease progression and the rising demand for personalized medicines are driving market expansion. Advances in sequencing technologies and bioinformatics have further accelerated epigenetic research, enabling more precise diagnostics and targeted therapies. This growing focus on epigenetic mechanisms across various fields is expanding the market and encouraging continuous innovation.
Epigenetics Market Report Highlights:
By product, the kits & reagents segment held the largest share in 2024 because they are essential for conducting epigenetic experiments and are widely used across research and clinical labs. Their versatility and ease of use make them the most sought-after product type.
By technology, the DNA methylation segment held the largest share in 2024 due to its critical role in gene regulation and disease studies, especially cancer. It is a well-established method widely used for diagnostics and therapeutic research.
By application, the oncology segment held the largest share in 2024 as epigenetic changes are closely linked to cancer development and treatment. The demand for epigenetic biomarkers and targeted therapies in cancer drives this segment's dominance.
By end use, the academic research segment held the largest share in 2024 since universities and research institutions are the primary users of epigenetic tools. Strong funding and ongoing studies make this segment key to market demand.
By region, North America is the leading region across the world due to its advanced healthcare infrastructure, high research funding, and early adoption of innovative epigenetic technologies. It remains a global hub for epigenetics research and application. The Asia Pacific is gaining attention for its growing investment in biotechnology and increasing focus on healthcare modernization. Rising awareness about the benefits of epigenetic research and the expanding prevalence of chronic diseases are encouraging adoption of epigenetic technologies.
A few key players in the market include Thermo Fisher Scientific, Merck KGaA, QIAGEN, New England Biolabs, Agilent Technologies, Bio-Rad Laboratories, EpiGentek, Zymo Research Corporation, Diagenode, Active Motif, PerkinElmer, and Illumina, Inc.
Polaris Market Research has segmented the epigenetics market report based on product, technology, application, end use, and region:
By Product Outlook (Revenue - USD Billion, 2020-2034)
Kits & Reagents
Enzymes
Equipment & Accessories
Software
Service
By Technology Outlook (Revenue - USD Billion, 2020-2034)
DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-coding RNA
MicroRNA modification
Chromatin structures
By Application Outlook (Revenue - USD Billion, 2020-2034)
Oncology
Metabolic Disorders
Immunology
Developmental Biology
Cardiovascular Diseases
Others
By End Use Outlook (Revenue - USD Billion, 2020-2034)
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Epigenetics Market Insights
- 4.1. Epigenetics Market - Market Snapshot
- 4.2. Epigenetics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Focus on Cancer Research and Personalized Medicine
- 4.2.1.2. Technological Advances in Epigenetic Analysis
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of Standardized Protocols and Interpretation
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Epigenetics Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Epigenetics Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 5.3. Kits & Reagents
- 5.3.1. Global Epigenetics Market, by Kits & Reagents, by Region, 2020-2034 (USD Billion)
- 5.4. Enzymes
- 5.4.1. Global Epigenetics Market, by Enzymes, by Region, 2020-2034 (USD Billion)
- 5.5. Equipment & Accessories
- 5.5.1. Global Epigenetics Market, by Equipment & Accessories, by Region, 2020-2034 (USD Billion)
- 5.6. Software
- 5.6.1. Global Epigenetics Market, by Software, by Region, 2020-2034 (USD Billion)
- 5.7. Service
- 5.7.1. Global Epigenetics Market, by Service, by Region, 2020-2034 (USD Billion)
6. Global Epigenetics Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 6.3. DNA Methylation
- 6.3.1. Global Epigenetics Market, by DNA Methylation, by Region, 2020-2034 (USD Billion)
- 6.4. Histone Methylation
- 6.4.1. Global Epigenetics Market, by Histone Methylation, by Region, 2020-2034 (USD Billion)
- 6.5. Histone Acetylation
- 6.5.1. Global Epigenetics Market, by Histone Acetylation, by Region, 2020-2034 (USD Billion)
- 6.6. Large non-coding RNA
- 6.6.1. Global Epigenetics Market, by Large non-coding RNA, by Region, 2020-2034 (USD Billion)
- 6.7. MicroRNA modification
- 6.7.1. Global Epigenetics Market, by MicroRNA modification, by Region, 2020-2034 (USD Billion)
- 6.8. Chromatin structures
- 6.8.1. Global Epigenetics Market, by Chromatin structures, by Region, 2020-2034 (USD Billion)
7. Global Epigenetics Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 7.3. Oncology
- 7.3.1. Global Epigenetics Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 7.4. Metabolic Disorders
- 7.4.1. Global Epigenetics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
- 7.5. Immunology
- 7.5.1. Global Epigenetics Market, by Immunology, by Region, 2020-2034 (USD Billion)
- 7.6. Developmental Biology
- 7.6.1. Global Epigenetics Market, by Developmental Biology, by Region, 2020-2034 (USD Billion)
- 7.7. Cardiovascular Diseases
- 7.7.1. Global Epigenetics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
- 7.8. Others
- 7.8.1. Global Epigenetics Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Epigenetics Market, by End-use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 8.3. Academic Research
- 8.3.1. Global Epigenetics Market, by Academic Research, by Region, 2020-2034 (USD Billion)
- 8.4. Clinical Research
- 8.4.1. Global Epigenetics Market, by Clinical Research, by Region, 2020-2034 (USD Billion)
- 8.5. Hospitals & Clinics
- 8.5.1. Global Epigenetics Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
- 8.6. Pharmaceutical & Biotechnology Companies
- 8.6.1. Global Epigenetics Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 8.7. Other Users
- 8.7.1. Global Epigenetics Market, by Other Users, by Region, 2020-2034 (USD Billion)
9. Global Epigenetics Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Epigenetics Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Epigenetics Market - North America
- 9.3.1. North America: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.3.2. North America: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.3.3. North America: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.3.5. Epigenetics Market - US
- 9.3.5.1. US: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.3.5.2. US: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.3.5.3. US: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.3.5.4. US: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.3.6. Epigenetics Market - Canada
- 9.3.6.1. Canada: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4. Epigenetics Market - Europe
- 9.4.1. Europe: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.2. Europe: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.3. Europe: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.5. Epigenetics Market - UK
- 9.4.5.1. UK: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.6. Epigenetics Market - France
- 9.4.6.1. France: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.6.2. France: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.6.3. France: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.6.4. France: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.7. Epigenetics Market - Germany
- 9.4.7.1. Germany: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.8. Epigenetics Market - Italy
- 9.4.8.1. Italy: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.9. Epigenetics Market - Spain
- 9.4.9.1. Spain: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.10. Epigenetics Market - Netherlands
- 9.4.10.1. Netherlands: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.11. Epigenetics Market - Russia
- 9.4.11.1. Russia: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.4.12. Epigenetics Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5. Epigenetics Market - Asia Pacific
- 9.5.1. Asia Pacific: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.5. Epigenetics Market - China
- 9.5.5.1. China: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.5.2. China: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.5.3. China: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.5.4. China: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.6. Epigenetics Market - India
- 9.5.6.1. India: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.6.2. India: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.6.3. India: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.6.4. India: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.7. Epigenetics Market - Malaysia
- 9.5.7.1. Malaysia: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.8. Epigenetics Market - Japan
- 9.5.8.1. Japan: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.9. Epigenetics Market - Indonesia
- 9.5.9.1. Indonesia: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.10. Epigenetics Market - South Korea
- 9.5.10.1. South Korea: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.11. Epigenetics Market - Australia
- 9.5.11.1. Australia: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.5.12. Epigenetics Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6. Epigenetics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6.5. Epigenetics Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6.6. Epigenetics Market - UAE
- 9.6.6.1. UAE: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6.7. Epigenetics Market - Israel
- 9.6.7.1. Israel: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6.8. Epigenetics Market - South Africa
- 9.6.8.1. South Africa: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.6.9. Epigenetics Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.7. Epigenetics Market - Latin America
- 9.7.1. Latin America: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.7.5. Epigenetics Market - Mexico
- 9.7.5.1. Mexico: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.7.6. Epigenetics Market - Brazil
- 9.7.6.1. Brazil: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.7.7. Epigenetics Market - Argentina
- 9.7.7.1. Argentina: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
- 9.7.8. Epigenetics Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Epigenetics Market, by Product, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Epigenetics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Epigenetics Market, by Application, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Epigenetics Market, by End-use, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Active Motif
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bio-Rad Laboratories, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Diagenode S.A.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. EpiGentek Group Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Illumina, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. New England Biolabs, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. PerkinElmer, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. QIAGEN N.V.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Zymo Research Corporation
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
